Overview

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

Status:
NOT_YET_RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
50 patients with anemia scheduled for heart surgery or procedures will be randomized to receive either oral sucrosomial iron or standard-of-care intravenous iron before surgery to see if the oral iron is as effective as intravenous iron in increasing the red blood cell count.
Phase:
PHASE4
Details
Lead Sponsor:
University of Rochester
Collaborator:
Pharmanutra S.p.a.
Treatments:
sucrosomial iron
Therapeutics